Nephros (NASDAQ:NEPH) Stock Price Up 1.3% – Should You Buy?

Shares of Nephros, Inc. (NASDAQ:NEPH) were up 1.3% during trading on Monday . The stock traded as high as $1.65 and last traded at $1.60. Approximately 28,392 shares were traded during mid-day trading, an increase of 168% from the average daily volume of 10,607 shares. The stock had previously closed at $1.58.

Analysts Set New Price Targets

Separately, Benchmark restated a “speculative buy” rating and issued a $5.00 target price on shares of Nephros in a research note on Tuesday, November 12th.

Nephros Price Performance

The firm has a fifty day moving average of $1.56 and a two-hundred day moving average of $1.67. The stock has a market capitalization of $16.81 million, a P/E ratio of -17.72 and a beta of 1.19.

Institutional Investors Weigh In On Nephros

A hedge fund recently bought a new stake in Nephros stock. Dimensional Fund Advisors LP purchased a new stake in shares of Nephros, Inc. (NASDAQ:NEPH) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 17,631 shares of the company’s stock, valued at approximately $37,000. Dimensional Fund Advisors LP owned about 0.17% of Nephros as of its most recent filing with the Securities & Exchange Commission. 41.10% of the stock is owned by hedge funds and other institutional investors.

Nephros Company Profile

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.